1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Takeda, A.
Wakamatsu, K.
Tachi, T.
Matsuzaki, K.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.0
90.0
90.0
1.0
1.0
1.0
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biopolymers
BIPMAA
0161
0006-3525
58
437
446
10.1002/1097-0282(20010405)58:4<437::AID-BIP1019>3.3.CO;2-9
11180056
Effects of peptide dimerization on pore formation: Antiparallel disulfide-dimerized magainin 2 analogue.
2001
10.2210/pdb1dum/pdb
pdb_00001dum
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2526.973
MAGAININ 2
F5Y, F16W
2
syn
polymer
no
no
GIGKYLHSAKKFGKAWVGEIMNS
GIGKYLHSAKKFGKAWVGEIMNS
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2001-06-27
1
1
2008-04-27
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
RCSB
Y
RCSB
2000-01-18
REL
REL
The peptide was prepared by solid-phase synthesis. The sequence of this peptide naturally occurs in Xenopus laevis (African clawed frog)
sample
This structure was determined using standard 2D homonuclear techniques.
structures with the lowest energy
100
10
2D NOESY
50mM
5.2
ambient
318
K
The structures are based on 466 NOE-derived distance constraints (per protomer), 32 of which are treated as ambiguous.
simulated annealing
1
lowest energy
5mM [F5Y, F16W] magainin 2,
0.5mM DLPC-d64
90% H2O/10% D2O
Bruker
collection
UXNMR
1.3
Brunger
refinement
X-PLOR
3.1
400
Bruker
ARX
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
GLY
3
n
3
GLY
3
A
LYS
4
n
4
LYS
4
A
TYR
5
n
5
TYR
5
A
LEU
6
n
6
LEU
6
A
HIS
7
n
7
HIS
7
A
SER
8
n
8
SER
8
A
ALA
9
n
9
ALA
9
A
LYS
10
n
10
LYS
10
A
LYS
11
n
11
LYS
11
A
PHE
12
n
12
PHE
12
A
GLY
13
n
13
GLY
13
A
LYS
14
n
14
LYS
14
A
ALA
15
n
15
ALA
15
A
TRP
16
n
16
TRP
16
A
VAL
17
n
17
VAL
17
A
GLY
18
n
18
GLY
18
A
GLU
19
n
19
GLU
19
A
ILE
20
n
20
ILE
20
A
MET
21
n
21
MET
21
A
ASN
22
n
22
ASN
22
A
SER
23
n
23
SER
23
A
GLY
1
n
1
GLY
1
B
ILE
2
n
2
ILE
2
B
GLY
3
n
3
GLY
3
B
LYS
4
n
4
LYS
4
B
TYR
5
n
5
TYR
5
B
LEU
6
n
6
LEU
6
B
HIS
7
n
7
HIS
7
B
SER
8
n
8
SER
8
B
ALA
9
n
9
ALA
9
B
LYS
10
n
10
LYS
10
B
LYS
11
n
11
LYS
11
B
PHE
12
n
12
PHE
12
B
GLY
13
n
13
GLY
13
B
LYS
14
n
14
LYS
14
B
ALA
15
n
15
ALA
15
B
TRP
16
n
16
TRP
16
B
VAL
17
n
17
VAL
17
B
GLY
18
n
18
GLY
18
B
GLU
19
n
19
GLU
19
B
ILE
20
n
20
ILE
20
B
MET
21
n
21
MET
21
B
ASN
22
n
22
ASN
22
B
SER
23
n
23
SER
23
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
B
B
O
H
ALA
GLY
9
13
1.43
1
A
A
O
H
ALA
GLY
9
13
1.47
1
B
B
O
H
PHE
TRP
12
16
1.57
1
A
A
O
H
PHE
TRP
12
16
1.58
1
B
B
O
H
LYS
ALA
4
9
1.59
2
A
A
O
H
ALA
GLY
9
13
1.46
2
A
A
O
H
PHE
TRP
12
16
1.52
2
B
B
O
H
ALA
GLY
9
13
1.57
3
B
B
O
H
ALA
GLY
9
13
1.43
3
A
A
O
H
ALA
GLY
9
13
1.43
4
B
B
O
H
ALA
GLY
9
13
1.46
4
A
A
O
H
ALA
GLY
9
13
1.50
4
A
A
O
H
PHE
TRP
12
16
1.59
5
A
A
O
H
ALA
GLY
9
13
1.46
5
B
B
O
H
ALA
GLY
9
13
1.56
5
B
B
O
H
PHE
TRP
12
16
1.59
6
A
A
O
H
ALA
GLY
9
13
1.47
6
B
B
O
H
ALA
GLY
9
13
1.49
6
B
B
O
H
PHE
TRP
12
16
1.57
6
A
A
O
H
PHE
TRP
12
16
1.58
7
A
A
O
H
ALA
GLY
9
13
1.45
7
A
A
O
H
PHE
TRP
12
16
1.48
7
B
B
O
H
PHE
TRP
12
16
1.58
7
B
B
O
H
ALA
GLY
9
13
1.58
8
A
A
O
H
ALA
GLY
9
13
1.42
8
B
B
O
H
ALA
GLY
9
13
1.45
8
B
B
O
H
LYS
ALA
4
9
1.46
8
B
B
O
H
PHE
TRP
12
16
1.53
9
A
A
O
H
ALA
GLY
9
13
1.41
9
A
A
O
H
LYS
ALA
4
9
1.54
9
A
A
O
H
PHE
TRP
12
16
1.57
9
B
B
O
H
ALA
GLY
9
13
1.58
10
B
B
O
H
ALA
GLY
9
13
1.43
10
A
A
O
H
ALA
GLY
9
13
1.44
10
A
A
O
H
LYS
SER
4
8
1.54
1
A
ILE
2
64.19
131.40
1
A
HIS
7
-149.39
13.48
1
A
SER
8
-165.39
-37.49
1
B
ILE
2
62.44
91.72
1
B
LYS
4
-146.36
-41.37
2
A
LYS
4
-158.87
-41.34
2
A
HIS
7
-131.14
-31.64
2
A
ALA
9
-51.19
-75.72
2
A
LYS
10
-29.16
-42.66
2
B
LYS
4
-148.61
-46.03
2
B
HIS
7
-141.29
12.91
2
B
SER
8
-164.89
-35.72
2
B
GLU
19
-91.89
-68.82
3
A
LYS
4
175.84
-48.45
3
A
SER
8
-157.98
-37.66
3
A
GLU
19
-91.32
-64.11
3
B
LYS
4
175.31
-46.22
3
B
HIS
7
-142.36
-32.97
3
B
LYS
10
-30.85
-39.20
4
A
LYS
4
-136.22
-41.56
4
A
HIS
7
-151.61
-28.42
4
A
ALA
9
-92.24
-63.80
4
A
GLU
19
-86.65
-72.44
4
B
LYS
4
-137.10
-45.94
4
B
SER
8
-168.94
-35.26
5
A
LYS
4
-147.26
-41.78
5
A
HIS
7
-140.31
12.51
5
A
SER
8
-165.85
-36.55
5
A
ALA
9
-60.40
-70.89
5
A
GLU
19
-91.32
-65.75
5
B
HIS
7
-152.81
-30.41
5
B
LYS
10
-39.64
-34.78
6
A
LYS
4
-144.05
-41.89
6
A
SER
8
-163.23
-36.32
6
B
ILE
2
51.66
78.65
6
B
LYS
4
-135.67
-44.68
6
B
SER
8
-158.24
-37.38
6
B
GLU
19
-86.82
-72.50
7
A
LYS
4
-136.77
-39.69
7
A
SER
8
-169.49
-37.93
7
A
GLU
19
-87.22
-71.32
7
B
LYS
4
-136.91
-39.35
7
B
SER
8
-171.16
-34.22
7
B
GLU
19
-87.69
-71.90
8
A
ILE
2
59.40
75.38
8
A
LYS
4
-137.70
-40.64
8
A
SER
8
-165.26
-36.26
8
A
LYS
10
-28.67
-48.05
8
A
GLU
19
-92.92
-61.57
8
B
SER
8
-141.90
-38.19
8
B
GLU
19
-90.63
-67.85
9
A
ILE
2
-153.66
70.51
9
A
LYS
4
-133.39
-35.01
9
A
HIS
7
-147.84
14.78
9
A
SER
8
-159.95
-39.42
9
A
LYS
10
-25.00
-54.15
9
A
GLU
19
-88.58
-71.61
9
B
ILE
2
62.67
63.39
9
B
LYS
4
-142.97
-47.54
9
B
SER
8
-167.27
-37.67
9
B
GLU
19
-105.94
-68.52
10
A
ILE
2
-163.44
63.85
10
A
LYS
4
-134.12
-43.81
10
A
HIS
7
-136.84
-30.87
10
A
GLU
19
-90.01
-63.93
10
B
HIS
7
-152.66
16.95
10
B
SER
8
-165.60
-38.99
10
B
GLU
19
-93.90
-65.43
NMR STRUCTURE OF [F5Y, F16W] MAGAININ 2 BOUND TO PHOSPHOLIPID VESICLES
1
N
N
1
N
N
A
SER
8
A
SER
8
HELX_P
A
MET
21
A
MET
21
1
1
14
B
SER
8
B
SER
8
HELX_P
B
MET
21
B
MET
21
1
2
14
ANTIMICROBIAL PROTEIN
antibiotic, magainin, dimer, amphipathic helix, membrane, vesicle, bilayer, ANTIMICROBIAL PROTEIN
MAGA_XENLA
UNP
1
129
P11006
MFKGLFICSLIAVICANALPQPEASADEDMDEREVRGIGKFLHSAGKFGKAFVGEIMKSKRDAEAVGPEAFADEDLDERE
VRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGPEAFADEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGP
EAFADEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVGPEAFADEDFDEREVRGIGKFLHSAKKFGKAFVGEI
MNSKRDAEAVGPEAFADEDLDEREVRGIGKFLHSAKKFGKAFVGEIMNSKRDAEAVDDRRWVE
129
151
1DUM
1
23
P11006
A
1
1
23
129
151
1DUM
1
23
P11006
B
1
1
23
1
PHE
engineered mutation
TYR
5
1DUM
A
P11006
UNP
133
5
1
PHE
engineered mutation
TRP
16
1DUM
A
P11006
UNP
144
16
2
PHE
engineered mutation
TYR
5
1DUM
B
P11006
UNP
133
5
2
PHE
engineered mutation
TRP
16
1DUM
B
P11006
UNP
144
16
1
P 1